Incyte (INCY) Stock Analysis & Research

Incyte (INCY) is a global biopharmaceutical company that discovers, develops, and commercializes therapeutics across hematology, oncology, and inflammation and autoimmunity. Its approved products include JAKAFI, OPZELURA, and PEMAZYRE, alongside royalty income from out-licensed drugs like JAKAVI and OLUMIANT.